{"id":"W3032902009","doi":"10.1007/s12032-020-01386-6","title":"NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials","year":2020,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gemcitabine; Internal medicine; Medicine; Carboplatin; Oncology; Deoxycytidine; Cisplatin; Clinical trial; Population; Deoxycytidine kinase; Phases of clinical research; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01420855,0.0006177811,0.01591644,0.001321821,0.00004296398,0.000008941273,0.0006982084,0.002949703,0.001502788],"category_scores_gemma":[0.1269536,0.0004373953,0.001100294,0.002001954,0.00123634,0.00003829311,0.0006784642,0.004642159,0.0003565841],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001457524,"about_ca_system_score_gemma":0.0186243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004704468,"about_ca_topic_score_gemma":0.00026427,"domain_scores_codex":[0.9817203,0.006686294,0.007541717,0.001296377,0.001462468,0.001292811],"domain_scores_gemma":[0.982006,0.01309963,0.00157828,0.0009995451,0.0003480376,0.001968572],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008658837,0.001914019,0.005524925,0.01275519,0.0005692988,0.002191675,0.00006182786,2.575786e-8,6.08335e-7,0.0006654531,0.01915956,0.9562916],"study_design_scores_gemma":[0.004412429,0.003221021,0.0006159403,0.01897339,0.001896082,0.0001504472,0.00002875042,0.00001324313,4.321319e-7,0.0001448585,0.9702585,0.0002849121],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003817833,0.9782774,0.0003017125,0.01053883,0.001136598,0.008104648,0.0001160016,0.00008426482,0.001058689],"genre_scores_gemma":[0.00003011384,0.9929304,0.002883481,0.0006146487,0.0009384042,0.001810205,0.0001478481,0.00007840521,0.0005665008],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9560066,"threshold_uncertainty_score":0.9998078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4032888797597849,"score_gpt":0.6122757373894707,"score_spread":0.2089868576296858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}